Financial Results for June 30, 2015 (Audited)
Caplin Point Laboratories Ltd has informed BSE about the Financial Results for the period ended June 30, 2015.20-08-2015
Financial Results for June 30, 2015 (Audited)
Caplin Point Laboratories Ltd has informed BSE about the Financial Results for the period ended June 30, 2015.Board recommends Dividend
Caplin Point Laboratories Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 20, 2015, inter alia, have:1. Recommended dividend of Rs.5 (Rupees five only) (50%) per equity share of Rs.10/- each (fully paid-up) for the financial year ended June 30, 2015 subject to the approval of the shareholders....Board to consider Dividend
Caplin Point Laboratories Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on August 20, 2015, inter alia, to consider the following:1. Audited Financial Results of the Company for the Financial year ended June 30, 20152. Recommendation of Dividend for the FY 2014-153. The Directors Report...Revised Shareholding Pattern For June 30, 2015
With reference to earlier announcement regarding Shareholding Pattern For June 30, 2015 dated July 10, 2015.Caplin Point Laboratories Ltd has now submitted to BSE a Revised Shareholding Pattern For June 30, 2015.Shareholding Pattern For June 30, 2015
Caplin Point Laboratories Ltd has informed BSE about the Shareholding Pattern as on June 30, 2015.Caplin Point gets EU GMP approval for Sterile Injectable Site
Caplin Point Laboratories Ltd has informed BSE regarding a Press Release dated July 08, 2015, titled "Caplin Point gets EU GMP approval for Sterile Injectable Site".Caplin Point listed on Forbes Asia's "200 Best Under a Billion" for second consecutive year
Caplin Point Laboratories Ltd has informed BSE regarding a Press Release dated July 02, 2015 titled "Caplin Point listed on Forbes Asia's "200 Best Under a Billion" for second consecutive year".Code of Conduct of Fair Disclosure
Caplin Point Laboratories Ltd has informed BSE regarding Disclosures under SEBI (Prohibition of Insider Trading) Regulations, 2015.Disclosures under Reg. 10(6) of SEBI (SAST) Regulations, 2011
C C Paarthipan has submitted the disclosures under Reg. 10(6) of SEBI (SAST) Regulations, 2011